Research Society on Marijuana
Marijuana Monthly (February)
The latest issue of the Marijuana Monthly is out! Check it out here: https://researchmj.org/resources/Marijuana%20Monthly%20February%202018.pdf
In this issue, we highlight work by two of RSMj’s members: Dr. Joseph DiVerdi and Dr. Robert Dvorak. We thank them for speaking with us about their work and we look forward to seeing how they continue to push the field forward.
#RSMj #cannabis #marijuana #science
Return of the Blog!
RSMj is back to discuss the latent cannabis-related science. Here is the first issue of Marijuana Monthly. It is an attempt to catalog all the peer-reviewed publications (indexed by PsycInfo or PubMed) related to cannabis. Check it out here: https://researchmj.org/resources/MM_0118.pdf
NIDA Monopoly Ends!
For nearly five decades, the University of Mississippi has been under contract with the National Institute on Drug Abuse (NIDA) as the only approved supplier of marijuana (and related compounds) for research purposes. To make a long, 48-year story short, this monopoly has ended, which will provide more opportunities for marijuana researchers! To learn more, check out the articles below:
Request for Information: Increasing the Varieties of Marijuana and Marijuana products for Research
Notice Number: NOT-DA-16-034
Release Date: July 7, 2016
Response Date: September 15, 2016
National Institute on Drug Abuse (NIDA)
The National Institutes of Health (NIH) recognizes that marijuana and/or its constituent compounds hold both risk and potential benefits to health. To date, the Food and Drug Administration (FDA) has approved one cannabinoid and one cannabinoid-like substance for medical use – synthetically-derived dronabinol, which is the pure isomer (-)-delta-9-tetrahydrocannabinol (THC, a constituent of marijuana), and nabilone, which is a synthetic substance similar to THC.
The National Institute on Drug Abuse (NIDA) supports the production of research grade marijuana and marijuana products (i.e. extracts, purified cannabinoids, etc.) for research. While there are a number of varieties of marijuana with differing constituent profiles currently available (primarily varying ratios of delta -9-THC and cannabidiol (CBD), but also several other cannabinoids; see https://www.drugabuse.gov/researchers/research-resources/nida-drug-supply-program-dsp/marijuana-plant-material-available-nida-drug-supply-program), NIDA is interested in gathering information on whether other specific marijuana varieties or marijuana-derived products are of interest to the research community.
NIDA is interested in gathering information from researchers conducting or interested in conducting research on marijuana and marijuana products on:
- The specific marijuana varieties, strains, or constituent chemotypes that are of research interest;
- The marijuana constituents, products and/or preparations that are of research interest; and,
- The particular research questions that could or would be addressed with such products.
If applicable, please describe why the currently available marijuana varieties are inadequate for your research project or interests (seehttps://www.drugabuse.gov/researchers/research-resources/nida-drug-supply-program-dsp/marijuana-plant-material-available-nida-drug-supply-program for a list of currently available materials).
How to Submit a Response
Responses will be accepted until September 15, 2016 through submissions to email@example.com. The collected information will be analyzed and may be used to guide future US Government efforts to provide adequate supplies of marijuana and marijuana products for research into the health risks and benefits.
Note: This RFI is for planning purposes only and should not be construed as a solicitation for applications or an obligation on the part of the government. The government will not pay for the preparation of any information submitted or for the government’s use of that information.
Inquiries concerning this Notice may be directed to firstname.lastname@example.org
My interest in conducting marijuana research and subsequently forming the Research Society on Marijuana stemmed from shock of how little we know about marijuana compared to other commonly used substances (e.g., alcohol, tobacco).
The plethora of knowledge gaps in the marijuana field is particularly troubling given the political climate. We find ourselves at a time when marijuana is being legalized for recreational use in one state after another state, and yet, science is not (and potentially cannot be) providing strong guidelines regarding how such policy changes should be enacted.
As stated in our mission statement, this is a time when we need more research attention dedicated to understanding the “determinants, correlates, consequences, contexts, and assessment of marijuana use as well as the treatment of problematic marijuana use, including cannabis use disorder.”